Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dollar Tree, Inc. (DLTR) vs Hims and Hers Health Inc (HIMS) Price & Performance

Dollar Tree, Inc.Trade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Dollar Tree, Inc. vs Hims and Hers Health Inc — how do they compare? Dollar Tree, Inc. trades at $127.65 (market cap $24.86B), while Hims and Hers Health Inc trades at $30.56 (market cap $7.35B). The key difference: Dollar Tree, Inc. is far larger — about 3.4× Hims and Hers Health Inc's market cap, and Dollar Tree, Inc. is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.

DLTRHIMS
Market Cap
$24.86B$7.35B
Sector
HealthHealth
52-Week High
$141.21$62.76
52-Week Low
$85.04$14.52
Enterprise Value
$31.45B$7.73B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dollar Tree, Inc.

Dollar Tree (DLTR) trades at $130.9, up 0.94% on the day, with a bullish technical outlook and strong profitability metrics including a 34.71% ROE. Recent quarters have consistently beaten EPS estimates, and the company announced a $2.5 billion share repurchase authorization in July 2026. Revenue for 2025 was $17.58 billion, though net income was negative due to a significant tax charge, with a rebound to profitability projected for 2026.

The stock presents a mixed outlook: analyst consensus is a 'Buy' with a $129.08 price target near the current price, supported by solid cash flow and margin improvements. Key risks include competitive pressures, tariff impacts on margins, and execution of the turnaround strategy amid consumer spending shifts.

Hims and Hers Health Inc

Hims & Hers Health stock trades at $31.59, up 6.51% today, showing strong momentum. The technical outlook is bullish, with the price above key moving averages and support at $30. Fundamentally, revenue growth is robust at 40% year-over-year in Q2 2026 (MarketBeat, 2026-08-10), but profitability remains challenged with a net loss margin of -0.56% in 2026. The company raised its annual revenue forecast to $3.1–3.3 billion (WSJ, 2026-08-10), reflecting confidence in subscriber growth and expansion into weight-loss treatments.

The investment outlook is mixed: strong revenue growth and bullish analyst targets near $35.60 offer upside, but high valuation ratios (P/E of 57.14) and recent earnings misses heighten risk. Key risks include margin pressure from GLP-1 investments and ongoing legal investigations. Wall Street sentiment is cautious, with 65% hold ratings, suggesting patience for profitability improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dollar Tree, Inc.

Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.

Read more on DLTR

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS